About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 447 record(s)
Req # A-2020-000073
Adverse Reaction Reports (AERs). Report numbers: E2B_02645175, E2B_02646038 E2B_02647196, E2B_02115045, 000729438.Organization: Health Canada
December 2020
Req # A-2020-000074
Adverse Reaction Reports (AERs) for METFORMIN HYDROCHLORIDE. Report numbers: 000725759, 000727705, E2B_02521674, E2B_02527157, E2B_02494049, E2B_02538128, E2B_02557565, E2B_02578431, E2B_02152974, E2B_00593225, E2B_02573709, E2B_02575168, 724874,…Organization: Health Canada
December 2020
Req # A-2020-000075
Adverse Reaction Reports (AERs) for METRONIDAZOLE. Report numbers: E2B_02637001, E2B_02615126, E2B_02618061, E2B_02535812, E2B_02285297, E2B_02510171, E2B_02532195, E2B_02534673 E2B_02393889, E2B_02564628, E2B_02571761.Organization: Health Canada
December 2020
Req # A-2020-000091
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02773221, E2B_02728372, E2B_02728380, E2B_02806518, E2B_02786877, E2B_02796010, E2B_02797568, E2B_02791675, E2B_02787601, E2B_02810156, E2B_02814222, E2B_02728448,…Organization: Health Canada
December 2020
Req # A-2020-000119
Adverse Reaction Reports (AERs). Report numbers: E2B_02329595, E2B_02329601, E2B_02332753, E2B_02332814, E2B_02332822, E2B_02332824, E2B_02335559, E2B_02336090, E2B_02378377, E2B_02427277, E2B_02428772, E2B_02441931, E2B_02449140, E2B_02450830,…Organization: Health Canada
December 2020
Req # A-2020-000142
Adverse Reaction Reports (AERs). Report numbers: E2B_02966111, E2B_02966170, E2B_02967216, E2B_02967223.Organization: Health Canada
December 2020
Req # A-2020-000147
Adverse Reaction Reports (AERs). Report numbers: E2B_02985249, E2B_02987894, E2B_02985739.Organization: Health Canada
December 2020
Req # A-2020-000199
Adverse Reaction Reports (AERs). Report numbers: E2B_02562480, E2B_02568526, E2B_02569033, E2B_02582494, E2B_02617874, E2B_02635358, E2B_02636496, E2B_02636497, E2B_02640883, E2B_02643402, E2B_02644533, E2B_02645141, E2B_02645142, E2B_02651943,…Organization: Health Canada
December 2020
Req # A-2020-000201
Adverse Reaction Reports (AERs). Report numbers: E2B_02477278, E2B_02611042, E2B_02519859, E2B_02597136, E2B_02631755, E2B_02634449, E2B_02665268, 000729743, E2B_02820523, E2B_02676060, E2B_02637001.Organization: Health Canada
December 2020
Req # A-2020-000202
Adverse Reaction Reports (AERs). Report numbers: 000722295, 000722243, E2B_02407239, E2B_02412024, E2B_02413346, E2B_02421333, E2B_02429137, 000725392, 000726356, 000725414, E2B_02472563.Organization: Health Canada
December 2020